The crossmatch may still be the most clinically relevant histocompatibility test performed.

Clinical transplants

Volumn , Issue , 2007, Pages 227-229

  Kerman, Ronald ^a   Lappin, Jacqueline ^a   Kahan, Barry ^a   Katz, Stephen ^a   McKissick, Eva ^a   Hosek, Kathleen ^a   Acorda, Noriel ^a   Wooley, Nicholas ^a   Hoover, Angela ^a   Miller, Kristah ^a   Rodriguez, Luis ^a   Moore, Brandt ^a   Melcher, Porsha ^a   Biedermann, Bridget ^a   Van Buren, Charles ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOTRANSPLANTATION; ARTICLE; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TEST; HUMAN; IMMUNOLOGY; KIDNEY TRANSPLANTATION; METHODOLOGY; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY;

FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSORBENT TECHNIQUES; KIDNEY TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 49149114772     PISSN: 08909016     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)